Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy

NCT02314156 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02314156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02314156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2015
Completion date
May 31, 2021
Enrollment
67 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation carrier, brca2 mutation carrier, ductal breast carcinoma in situ, lobular breast carcinoma in situ, stage 0 breast cancer, stage ia breast cancer, stage ib breast cancer, stage iia breast cancer, stage iib breast cancer